[Sources: Alphabet's Isomorphic Labs in Talks to Raise Around $5 Billion] According to Bloomberg, citing sources familiar with the matter, Alphabet's AI drug discovery company, Isomorphic Labs, is in talks to raise approximately $5 billion in new funding, which would value it at around $50 billion. The sources stated that the funding round is not yet finalized and details are subject to change. Isomorphic Labs, spun out of Google's DeepMind in 2021, conducts drug discovery based on the AlphaFold protein structure prediction model. In May of this year, it completed a $2.1 billion funding round led by Thrive Capital, with participation from Alphabet and others.